RDY – Dr. Reddy’s Laboratories Limited
Dr. Reddy's Laboratories LtdRDY
$15.03Name : Dr. Reddy's Laboratories Ltd
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $12,604,232,704.00
EPSttm : 0.79
Dr. Reddy's Laboratories Ltd
$15.03
0.27%$0.04Float Short %
1.5
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
15.03
Target Price
14.77
Analyst Recom
2.85
Performance Q
13.86
Relative Volume
0.71
Beta
0.33
Ticker: RDY
No data found
No data found
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | RDY | 0 | 21.13 | 1.79 |
| 2025-06-03 | RDY | 0 | 21.13 | 1.79 |
| 2025-06-04 | RDY | 0 | 21.13 | 1.79 |
| 2025-06-05 | RDY | 0 | 21.13 | 1.79 |
| 2025-06-06 | RDY | 0 | 21.13 | 1.79 |
| 2025-06-09 | RDY | 0 | 21.09 | 1.79 |
| 2025-06-10 | RDY | 0 | 21.09 | 1.79 |
| 2025-06-11 | RDY | 0 | 21.09 | 1.71 |
| 2025-06-12 | RDY | 0 | 21.09 | 1.71 |
| 2025-06-13 | RDY | 0 | 21.09 | 1.71 |
| 2025-06-16 | RDY | 0 | 20.87 | 1.71 |
| 2025-06-17 | RDY | 0 | 20.87 | 1.71 |
| 2025-06-18 | RDY | 0 | 20.87 | 1.71 |
| 2025-06-20 | RDY | 0 | 20.87 | 1.71 |
| 2025-06-23 | RDY | 0 | 20.88 | 1.71 |
| 2025-06-24 | RDY | 0 | 20.88 | 1.71 |
| 2025-06-25 | RDY | 0 | 20.88 | 1.71 |
| 2025-06-26 | RDY | 0 | 20.88 | 1.50 |
| 2025-06-27 | RDY | 0 | 20.88 | 1.50 |
| 2025-06-30 | RDY | 0 | 28.89 | 1.50 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
28.89
Beta
0.33
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
Growth Score
Sentiment Score
Actual DrawDown %
Max Drawdown 5-Year %
Target Price
14.77
P/E
18.77
Forward P/E
23.24
PEG
P/S
3.25
P/B
3.22
P/Free Cash Flow
36.24
EPS
0.8
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
17.32
Relative Volume
0.71
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Dr. Reddy's Laboratories LtdSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 27811
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
stock quote shares RDY – Dr. Reddy’s Laboratories Limited Stock Price stock today
news today RDY – Dr. Reddy’s Laboratories Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch RDY – Dr. Reddy’s Laboratories Limited yahoo finance google finance
stock history RDY – Dr. Reddy’s Laboratories Limited invest stock market
stock prices RDY premarket after hours
ticker RDY fair value insiders trading